Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Research suggests link between loss of smell from COVID and cognitive decline

Por: ABC7 Health December 27, 2022

thumbnail

If a COVID-19 infection took away your sense of smell, you're not alone.Research shows more than 27 million people have experienced COVID-related smell or taste loss.We don't really understand why that happens, said Dr. Justin Turner, an associate professor of otolaryngology-head and neck surgery at Vanderbilt University Medical Center. We believe it's due to some sort of inflammatory response of the smell nerve that occurs in... + full article



Similar News

Scientists have a theory on COVID loss of smell: Damage to nasal cells

Portland Press Herald USA Health December 22, 2022

thumbnailPersistent loss of smell has left some COVID-19 survivors yearning for the scent of their freshly bathed child or a waft of their once-favorite meal. It’s left others inured to the stink of garbage and accidentally drinking spoiled milk. “Anosmia,” as experts call it, is... + más

Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico

A Devious Cellular Trick Cancers Can Use to Escape Your Immune System | The New York Times


Ultra-processed foods linked to cognitive decline, dementia: study

New York Post USA Life December 06, 2022

thumbnailUltra-processed foods might make our lives easier and taste delicious, but they might have detrimental impacts down the line — possibly leading to dementia. A new study published in on Monday found that people could be at a higher risk of cognitive decline if more than 20% of... + más

Eating 400 calories a day from these foods could raise your dementia risk by over 20% | MarketWatch

Eating 400 calories a day from these foods could raise your dementia risk by over 20% | MarketWatch


New test can detect plaques early in the disease: Alzheimer's Q&A

The Advocate USA Health November 16, 2022

thumbnailWhat is the Lumipulse test for Alzheimer’s disease?In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, Inc. of Malvern, Pennsylvania. The test, which was granted Breakthrough Device... + más

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes

Why Isn’t There an Effective Alzheimer’s Treatment Yet? | Slate


Alzheimer's Q&A: Engaging brain can reduce disease risk

The Advocate USA Health November 16, 2022

thumbnailWhat is meant by cognitive reserve?Cognitive reserve is the mind’s resistance to damage to the brain.It is an evidence-based idea proposed by Columbia University neuropsychologist Dr. Yaakov Stern in the mid-1990s which described individuals with no apparent symptoms of... + más

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes

COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald


Smell Loss Persists After COVID for Millions of People. Life-Long Anosmics Have a Warning for Them.

Slate USA Health September 24, 2022

thumbnailDia Kline was 4 years old when she first realized there was a thing called smell, and she couldn’t do it. “I remember walking into my home with my father and brother, and as soon as we walked through the front door, they both said, ‘Ah, spaghetti for dinner.’ ” Kline... + más

I recovered from COVID but my nose didn't. Here's how I cope | Los Angeles Times

The Hidden World of Scents Outside Your Door | The Atlantic


New test can detect plaques early in the disease: Alzheimer's Q&A

The Advocate USA Health September 17, 2022

thumbnailWhat is the Lumipulse test for Alzheimer’s disease?In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, Inc. of Malvern, Pennsylvania. The test, which was granted Breakthrough Device... + más

Variety of factors play a role in the development of Alzheimer's | The Advocate

Alzheimer's Q&A: Sildenafil has potential as Alzheimer's drug | The Advocate


Alzheimer's Q&A: Engaging brain can reduce disease risk

The Advocate USA Health September 17, 2022

thumbnailWhat is meant by cognitive reserve?Cognitive reserve is the mind’s resistance to damage to the brain.It is an evidence-based idea proposed by Columbia University neuropsychologist Dr. Yaakov Stern in the mid-1990s which described individuals with no apparent symptoms of... + más

Variety of factors play a role in the development of Alzheimer's | The Advocate

There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate



About iurex | Privacy Policy | Disclaimer |